MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Feb. 14, 2006--VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH), a New Jersey-based biopharmaceutical company focused on acquiring, developing and commercializing targeted cancer compounds, in addition to providing chiral products and services through its subsidiary Chiral Quest, will present a corporate overview at the BIO CEO & Investor Conference 2006 on Wednesday, February 15, at 4:00 PM (EST). The presentation will take place in the Basildon Room at The Waldorf Astoria in New York City.